Covid Clinic- Episode 10 | All You Need To Know About Antiviral Drug Favipiravir

In this episode of Covid Clinic, Dr Indranill Basu Ray talks about the oral anti-viral drug Favipiravir launched by Glenmak Pharmaceuticals for the treatment of mild to moderate Covid-19 patients in India. Dr Ray says Favipiravir prevents the replication of virus inside the body and has been found to be effective in Covid-19 and a wide variety of similar functions. Favipiravir has received regulatory approval in India, and it has also been a subject of multiple trials across several countries. The drug, sold under the brand name Avigan, is used to treat influenza in Japan. However, reduce dose needs to be administered to people suffering from liver disease. If you have any covid-related questions, write to us at covidclinic@outlookindia.com
02 July 2020

SHOW COMMENTS

  • MORE FROM OUTLOOK
X